Cytokinetics, Incorporated (CYTK) vs TG Therapeutics, Inc. (TGTX)
- Cytokinetics, Incorporated CYTK 61.95 −3.08%
- TG Therapeutics, Inc. TGTX 53.97 −3.63%
Cytokinetics, Incorporated and TG Therapeutics, Inc. are both Biotechnology companies. Cytokinetics, Incorporated and TG Therapeutics, Inc. are of similar size ($8.9B and $8.6B). Cytokinetics, Incorporated has negative trailing earnings, so its P/E is not meaningful; TG Therapeutics, Inc. trades at 17.8×. TG Therapeutics, Inc. grew revenue faster over the last twelve months: 76.1% against −21.1%. TG Therapeutics, Inc. has the higher net margin (55.2% vs −1,321.1%) and the higher return on invested capital (10.7% vs 0.00%). Across the 17 metrics below, TG Therapeutics, Inc. leads on 12 and Cytokinetics, Incorporated on 5.
Valuation
Profitability
| Metric | CYTK | TGTX | Biotechnology median |
|---|---|---|---|
| Gross margin | 87.97% | 82.37% | 65.16% |
| Operating margin | (1,046.12%) | 17.05% | 0.00% |
| Net margin | (1,321.12%) | 55.22% | 0.00% |
| Free cash flow margin | (858.16%) | 2.17% | 0.00% |
| Return on equity | 329.76% | 100.28% | (56.36%) |
| Return on assets | (56.76%) | 37.70% | (48.04%) |
| Return on invested capital | 0.00% | 10.69% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack